Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2– breast cancer (LEADER)

Title:	Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2– breast cancer (LEADER)
Authors:	Spring, Laura M.^Aff1; Scarpetti, Lauren^Aff1; Medford, Arielle J.^Aff1; Niemierko, Andrzej^Aff1; Comander, Amy^Aff1; Mulvey, Therese^Aff1; Schnipper, Lowell^Aff2; Isakoff, Steven J.^Aff1; Moy, Beverly^Aff1; Wander, Seth A.^Aff1; Shin, Jennifer^Aff1; Ephrem, Zanta^Aff1; Laposta, Anneke R.^Aff1; Denault, Elyssa^Aff1; Abraham, Elizabeth^Aff1; Calistro, Gayle^Aff1; Kalashnikova, Ekaterina^Aff3; Rodriguez, Angel^Aff3; Liu, Minetta C.^Aff3; Aleshin, Alexey^Aff3; Peppercorn, Jeffrey^Aff1; Ellisen, Leif W.^Aff1; Bardia, Aditya^{Aff1, Aff4, IDs41523024007085_cor1}
Source:	npj Breast Cancer. 11(1)
Database:	Springer Nature Journals